The endocannabinoid system as an emerging target of pharmacotherapy
about
Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cellsCannabinoids for fibromyalgiaFatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injuryTaming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effectsDevelopmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodentsBiochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseMarijuana use and long-term mortality among survivors of acute myocardial infarctionIs lipid signaling through cannabinoid 2 receptors part of a protective system?Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI.Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicityCB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytesThe cannabinoid CB2 receptor as a target for inflammation-dependent neurodegenerationNovel cannabinoid receptorsCannabinoids for fibromyalgiaCannabinoids for chronic neuropathic painEndocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceCannabinoid receptor type-1: breaking the dogmasThe involvement of TRPV1 in emesis and anti-emesisAnticancer mechanisms of cannabinoidsCannabis sativa: The Plant of the Thousand and One MoleculesEmerging drugs of abuse: current perspectives on synthetic cannabinoidsAn Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's DiseaseLegal highs: staying on top of the flood of novel psychoactive substancesOntogenetic modifications of neuronal excitability during brain maturation: developmental changes of neurotransmitter receptorsChemical probes of endocannabinoid metabolismIs the cardiovascular system a therapeutic target for cannabidiol?Cannabinoids as therapeutic agents in cancer: current status and future implicationsInterplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathyMarijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalizationThe role of endocannabinoids system in fatty liver disease and therapeutic potentialsModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionImmune mechanisms in cerebral ischemic toleranceMetabolic syndrome: an important risk factor for Parkinson's diseaseTriphasic blood pressure responses to cannabinoids: do we understand the mechanism?Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmissionDiscovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory PainPrecision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive AstrocytesEndocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetesPharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndromePhenazepam and cannabinomimetics sold as herbal highs in New Zealand
P2860
Q21144343-93E198C9-80B0-4F19-9DC6-355BD1F13ED0Q24188267-909EAF2F-C2DA-4A22-8273-6E1928C547ADQ24595633-AA71F033-7B34-490F-B4B5-1508E077C620Q24606148-78050AF8-470A-4E39-B041-E091D5D836B9Q24613945-A35E9DAB-2B3E-4849-9E60-9F63EC0C1583Q24620186-B57E5868-7D7A-4EF6-A6C2-6EC26C7C6E78Q24629571-0E1B40BE-B2EA-4ADF-AFB5-5DBB5804A0B9Q24633122-1EFFF5FD-5767-4E3E-BF66-09287D679EDEQ24643957-F56ECDC1-497C-498A-85B4-D6F43DEAE54AQ24648835-9F01EC26-C40F-47BC-B3A6-41F22A5C2011Q24649936-20371D3C-E9B9-40C5-9822-046F780D4242Q24651712-0925C160-42FB-4480-BE9A-9C683101B616Q24681482-287ED717-CFE4-44E0-8626-D1D03C517BE9Q26471052-7FC17783-CB61-4672-AFD1-37B37B7A94D8Q26472068-EE07DA71-1B81-423C-AB02-C947B64F237FQ26739831-0A6F80A9-46EF-4093-8052-1E767305D229Q26745261-A5D88700-877F-4B40-901C-B82FAF8A94C9Q26745801-E8BBEC25-2E8B-4E9B-8D8A-01984417FBADQ26750399-C7CDDDB1-C435-4A0D-BBA6-78D522E50E0FQ26766409-0A92542F-B316-46B1-B026-9610577BBC51Q26778885-45A3FDE0-A037-40BD-BED5-FBC2E6757CB1Q26796027-88609863-E26F-4DCD-8E74-01682A5730D2Q26799231-875A94E7-3B4F-42BD-B1B2-3723225F2689Q26823747-0C2151C7-727E-4C2A-9E20-93CAB6E75432Q26863202-B171E668-C8B2-4963-AD4C-F3DA956956E0Q26865370-79432A09-8B52-4470-B157-C8CCE7C7DDBEQ26866298-940123A2-164F-4A9F-8A6B-96B1DC6EA999Q27001165-EB245492-5901-469A-AB3E-5A2A878C5643Q27009287-A2114E3A-8858-44F7-A735-A47DD796024AQ27009466-A9F70F28-9CD5-4EA0-92FE-8845883BF95CQ27014154-298F6994-E566-4114-B823-4DBCAD0C3964Q27022067-3337EFDF-4CCC-40B6-B1BB-8D30CE1EDF54Q27023711-861A4FE3-2EA0-428C-A39F-0C3C8F966D31Q27025612-F01CEB80-ACB0-4855-9BA9-653DA1A994FFQ27307029-B913C718-0F39-4AF1-8200-74D818EB21A9Q27655121-0A15622F-DEFD-4050-9341-49179C91E711Q28078621-48E37B1D-79F1-492D-884D-B7058A83D343Q28078897-C8B25424-1F0A-464D-B93E-A1A7C681341DQ28244460-C4F8FEF2-0758-41B0-86A4-C4C12C5886DCQ28273694-2571D51F-B6E1-4D27-8B9B-FB18F276BF67
P2860
The endocannabinoid system as an emerging target of pharmacotherapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The endocannabinoid system as an emerging target of pharmacotherapy
@ast
The endocannabinoid system as an emerging target of pharmacotherapy
@en
The endocannabinoid system as an emerging target of pharmacotherapy
@nl
type
label
The endocannabinoid system as an emerging target of pharmacotherapy
@ast
The endocannabinoid system as an emerging target of pharmacotherapy
@en
The endocannabinoid system as an emerging target of pharmacotherapy
@nl
prefLabel
The endocannabinoid system as an emerging target of pharmacotherapy
@ast
The endocannabinoid system as an emerging target of pharmacotherapy
@en
The endocannabinoid system as an emerging target of pharmacotherapy
@nl
P2093
P2860
P3181
P356
P1476
The endocannabinoid system as an emerging target of pharmacotherapy
@en
P2093
George Kunos
Pál Pacher
Sándor Bátkai
P2860
P304
P3181
P356
10.1124/PR.58.3.2
P407
P577
2006-09-01T00:00:00Z